Netherlands· NL-cd83c7c6c0a8
Lonquex 6 mg, oplossing voor injectie
A lipegfilgrastim product containing lipegfilgrastim, registered in Netherlands by Teva B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Lipegfilgrastim is registered in 12 of 19 countries.
Countries holding a registration under ATC L03AA14 (lipegfilgrastim), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Lipegfilgrastim · ATC L03AA14
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LIPEGFILGRASTIM
- Manufacturer
- Teva B.V.
- Country
- Netherlands (NL)
- ATC code
- L03AA14
- ATC class
- Lipegfilgrastim
- Defined daily dose
- 0.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/13/856
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lipegfilgrastim in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceLONQUEX 6 mg, solution injectable en seringue préremplieTEVA (PAYS-BAS)
- IrelandLonquex 6 mg solution for injection in pre-filled syringeTeva B.V.
- FinlandLonquexAbacus Medicine A/S
- CzechiaLONQUEXTeva B.V., Haarlem
- SwedenLonquex 6 mg Injektionsvätska, lösning i förfylld sprutaTeva B.V.
- SpainLONQUEX 6 MG/0,6 ML SOLUCION INYECTABLETeva B.V.
- NorwayLonquexTeva B.V.
- BelgiumLonquex 6 mgTeva
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Lonquex
- Iceland · Lonquex
- Liechtenstein · Lonquex
- Norway · Lonquex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a5a5b972-b2c7-4538-a525-36db58c0874d GET /v1/drugs/a5a5b972-b2c7-4538-a525-36db58c0874d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/lonquex-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Lipegfilgrastim",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp111069",
"excipients": [
"AZIJNZUUR (E 260)",
"NATRIUMHYDROXIDE (E 524)",
"POLYSORBAAT 20 (E 432)",
"SORBITOL (E 420)",
"WATER VOOR INJECTIE"
],
"substances": [
"LIPEGFILGRASTIM"
],
"leaflet_url": null,
"authorised_at": "2013/07/25",
"procedure_number": "EMEA/H/C/002556",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/13/856",
"additional_monitoring": "N"
}See everything about lipegfilgrastim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.